INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

352 studies · page 10 of 15

2011 / Narrative review

Current evidence indicates no role for oral DHEA supplementation in healthy, postmenopausal women.

This review examined published literature on DHEA supplementation in postmenopausal women. Daily oral DHEA achieves serum levels seen in women in their 20s. Interventional trials show no improvement in atherosclerosis or cardiovascular risk factors, and demonstrate a lowering of HDL cholesterol levels. DHEA modestly increases bone mineral density with adjuvant therapies and improves cognition in women with mild-to-moderate cognitive impairment, but not unimpaired women; intravaginal, but not oral, DHEA improves vaginal atrophy and sexual function.

Goel RM, Cappola AR Curr Opin Endocrinol Diabetes Obes, 2011. PMID 21478748

2011 / Clinical practice guideline

The Endocrine Society guideline recommends vitamin D supplementation and serum 25(OH)D testing for at-risk patients, but not routine screening for others.

An Endocrine Society Task Force developed clinical practice guidelines for evaluating, treating, and preventing vitamin D deficiency based on systematic reviews of evidence. The Task Force recommended vitamin D supplementation at suggested daily intake and tolerable upper limit levels depending on age and clinical circumstances, and treatment with vitamin D2 or vitamin D3 for deficient patients. Serum 25-hydroxyvitamin D measurement was recommended for patients at risk for deficiency. Currently, there is insufficient evidence to recommend screening individuals not at risk or prescribing vitamin D for cardiovascular protection.

Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. J Clin Endocrinol Metab, 2011. PMID 21646368

2011 / Narrative review / commentary

A review argues that the minimum desirable serum 25-hydroxyvitamin D level should exceed 75 nmol/L rather than the IOM recommendation of 50 nmol/L.

This article examines the Institute of Medicine (IOM) recommendation to maintain serum 25-hydroxyvitamin D (25(OH)D) at or above 50 nmol/L. The author argues that 25(OH)D should preferably exceed 75 nmol/L (30 ng/mL) based on re-evaluation of bone density and osteomalacia data, evolutionary biology, clinical trials, and epidemiological links to fewer falls, better tooth attachment, less colorectal cancer, and improved depression. The author attributes reported risks of prostate cancer, pancreatic cancer, or mortality at higher latitudes to dynamic seasonal fluctuations in 25(OH)D.

Vieth R Best Pract Res Clin Endocrinol Metab, 2011. PMID 21872808

2011 / Review

Gout incidence is rising, with risk linked to diet such as high fructose drinks, red meat, organ meats, seafood, and alcohol.

This article reviews the epidemiology, risk factors, and progression of gout. The incidence of gout is increasing, predominantly among the elderly. Dietary factors appearing to increase the risk of developing gout include high fructose drinks, red meat, organ meats, fatty seafood, and beer or liquor, alongside conditions such as hyperuricemia, hypertension, and renal disease. Progression can range from asymptomatic hyperuricemia to chronic gout causing tophi deposits, deformity, and bone and cartilage damage.

Shows an association, not proof of cause and effect.

Zychowicz ME Orthop Nurs, 2011. PMID 21934587

2010 / Benefit-risk review of RCTs and prospective cohorts

Review suggests serum 25(OH)D levels of 75 to 110 nmol/l provide optimal benefits for falls, fractures, and other endpoints without increasing health risks.

This study evaluated the benefits and risks of higher vitamin D doses and achieved 25(OH)D levels using double-blind RCTs and prospective cohort data. Based on RCTs for falls (n = 2,426) and non-vertebral fractures (n = 42,279), optimal benefits were observed at 700 to 1,000 IU/day or mean 25(OH)D between 75 and 110 nmol/l. Prospective cohort data on cardiovascular health and colorectal cancer suggested increased benefits with the highest categories evaluated (median 75 to 110 nmol/l). In 25 RCTs, oral vitamin D up to 100,000 IU/day or achieved 25(OH)D up to 643 nmol/l was not related to mean serum calcium, and levels of 75 to 110 nmol/l were reached in most RCTs with 1,800 to 4,000 IU/day without risk.

Bischoff-Ferrari HA, Shao A, Dawson-Hughes B, et al. Osteoporos Int, 2010. PMID 19957164

2010 / Narrative review

Optimal circulating 25-hydroxyvitamin D is estimated at 30 to 32 ng/mL or above, with low levels prevalent in approximately three-quarters of US adults.

Vitamin D status is best evaluated by circulating 25-hydroxyvitamin D (25(OH)D), with optimal levels increasingly agreed to be approximately 30 to 32 ng/mL or above. By this threshold, approximately three-quarters of US adults are estimated to have low levels, which has classic skeletal consequences like osteomalacia/rickets and recognized associations with nonskeletal morbidities. Achieving optimal status requires daily intakes of at least 1000 IU or more of vitamin D, while the risk of toxicity from high intakes is low. Substantial between-individual variability exists in response to the same vitamin D dose, and supplementation with vitamin D(3) may be preferable to vitamin D(2).

Binkley N, Ramamurthy R, Krueger D Endocrinol Metab Clin North Am, 2010. PMID 20511052

2010 / Narrative review

Bone loss in aging women and men is driven largely by sex steroid deficiency, alongside factors like vitamin D deficiency and hyperparathyroidism.

This review examines the physiological mechanisms underlying bone loss in aging women and men. Estrogen deficiency is identified as the main cause of early rapid postmenopausal bone loss in women and also plays a dominant role in aging men, while vitamin D deficiency and hyperparathyroidism contribute to later age-related bone loss in women. Other contributing factors include impaired osteoblast bone formation, growth hormone/insulin-like growth factor axis impairment, reduced peak bone mass, sarcopenia, adipocyte-secreted leptin, and intestinal serotonin.

Clarke BL, Khosla S Radiol Clin North Am, 2010. PMID 20609887

2010 / Narrative review

Whole soy foods show positive associations with bone health, while isolated soy protein and purified isoflavone trials yield inconsistent findings.

Epidemiological studies in Asia evaluating diets with traditional whole soy foods show a positive association with bone mineral density and fracture protection. In contrast, smaller-scale Western intervention studies using isolated soy protein or purified soy isoflavones have produced inconsistent results. Soy protein consumption does not alter calcium retention despite reducing urinary calcium excretion compared to proteins higher in sulfur-containing amino acids, raising the question of whether whole soy offers superior bone benefits.

Reinwald S, Weaver CM J Nutr, 2010. PMID 20980647

2009 / Narrative review

Review indicates dried plum improves bone indices in animal models and increases bone formation markers in postmenopausal women.

This review summarizes findings on the effects of dried plum (prunes) on bone health across animal models and a clinical trial. Animal studies demonstrated that dried plum prevented and reversed bone loss, restored bone mineral density, and improved trabecular architecture. In a 3-month clinical trial, daily dried plum consumption by postmenopausal women significantly increased serum markers of bone formation: total alkaline phosphatase by 12%, bone-specific alkaline phosphatase by 6%, and insulin-like growth factor-I by 17%.

Hooshmand S, Arjmandi BH Ageing Res Rev, 2009. PMID 19274852

2009 / Narrative review

Strict sun protection can cause vitamin D deficiency, which is linked to several diseases, while 1000-2000 IU daily intake may reduce these risks.

This review analyzes literature addressing the balance between UV protection for skin cancer prevention and avoiding vitamin D deficiency. About 90% of the body's required vitamin D is formed via skin UV-B exposure, and strict sun protection has been shown to cause vitamin D deficiency. Vitamin D deficiency is associated with multiple conditions, including various cancers, bone diseases, autoimmune diseases, infectious diseases, cardiovascular diseases, and hypertension. Most experts suggest a daily intake of 1000-2000 IU of vitamin D could decrease the incidence of deficiency-related diseases with minimal risk.

Reichrath J Br J Dermatol, 2009. PMID 19775358

2008 / Narrative review

Glucosamine sulfate and chondroitin sulfate may reduce osteoarthritis symptoms, while other supplements lack sufficient long-term evidence.

This review evaluates dietary supplements commonly used by patients with osteoarthritis. Most research suggests that glucosamine sulfate can improve pain symptoms and slow disease progression in knee osteoarthritis, while chondroitin sulfate also appears to reduce symptoms, though evidence does not show their combination is more effective than either agent alone. S-adenosylmethionine may reduce pain, but high costs and quality issues limit its use. Other supplements like methylsulfonylmethane, devil's claw, turmeric, and ginger lack sufficient reliable evidence regarding long-term safety or effectiveness.

Gregory PJ, Sperry M, Wilson AF Am Fam Physician, 2008. PMID 18246887

2008 / Narrative review

A review reported optimal serum 25(OH)D levels appeared to be at least 75 nmol/l for multiple endpoints and 90-120 nmol/l for cancer prevention.

This review summarizes evidence from studies evaluating threshold levels for serum 25(OH)D in relation to bone mineral density, lower extremity function, dental health, falls, nursing home admission, fractures, cancer prevention, and incident hypertension. For all evaluated endpoints, the most advantageous serum 25(OH)D levels appeared to be at least 75 nmol/l (30 ng/ml), and between 90-120 nmol/l (36-48 ng/ml) for cancer prevention. The authors state that an intake of no less than 1000 IU (25 mcg) vitamin D3 daily for all adults may bring at least 50% of the population up to 75 nmol/l, while estimates suggest 2000 IU daily may safely achieve the desired range for most individuals, though implications require future study.

Shows an association, not proof of cause and effect.

Bischoff-Ferrari HA Adv Exp Med Biol, 2008. PMID 18348447

2007 / Narrative review

Dietary phosphorus restriction across all stages of adult renal failure can help manage phosphorus balance and slow renal disease progression.

Hyperphosphatemia and hyperparathyroidism in end-stage renal disease are linked to renal osteodystrophy, organ calcification, cardiovascular disease, and sudden death. Restricting dietary protein and phosphorus is beneficial for slowing renal failure progression and is recommended across all stages of adult renal failure. Dialysis patients absorb 60-80% of dietary phosphorus, which can drop to 40% with phosphate binders. Conventional hemodialysis removes about 30 mmol (900 mg) of phosphorus thrice weekly, making 750 mg of dietary phosphorus intake the critical threshold to prevent a positive phosphorus balance, corresponding to 45-50 g/day or 0.8 g/kg/day of protein for a 60 kg patient.

Takeda E, Yamamoto H, Nishida Y, et al. Contrib Nephrol, 2007. PMID 17369719

2007 / Narrative review

Only about one-third to one-half of people can convert the soy isoflavone daidzein into equol via intestinal microflora.

Soy isoflavones are linked to lower rates of cardiovascular disease, osteoporosis, and some cancers. Clinical efficacy may rely on biotransforming daidzein into equol, a metabolite with greater estrogen receptor affinity, antiandrogenic properties, and superior antioxidant activity. Only about one-third to one-half of the population can produce equol, likely due to interindividual variations in gut microflora, though specific bacterial species responsible remain to be identified.

Shows an association, not proof of cause and effect.

Yuan JP, Wang JH, Liu X Mol Nutr Food Res, 2007. PMID 17579894

2005 / Narrative review

Current adult dietary intake recommendations of 200–600 IU/d are inadequate to maintain circulating 25(OH)D at or above sufficiency levels (80 nmol or 32 µg/L).

This review evaluates methods for defining vitamin D sufficiency and the adequacy of dietary intake guidelines. Biomarkers such as intact parathyroid hormone, calcium absorption, and bone mineral density indicate that vitamin D deficiency is more accurately defined as circulating 25(OH)D levels of 80 nmol/L or 32 µg/L or lower. Current dietary recommendations for adults (200–600 IU/d) are insufficient to maintain circulating 25(OH)D at or above this threshold, particularly during pregnancy and lactation.

Hollis BW J Nutr, 2005. PMID 15671234

2005 / Systematic review

A review of studies in children and young adults found scant evidence that dairy products or dietary calcium consistently benefit bone health.

Researchers reviewed 58 studies evaluating the relationship between dairy products or calcium intake and bone mineralization or fracture risk in individuals aged 1 to 25 years. Eleven studies were excluded for failing to control for weight, pubertal status, and exercise. Among 10 randomized controlled trials of calcium supplements, 9 showed modest positive benefits on bone mineralization. However, of the remaining 37 studies on dairy or unsupplemented dietary calcium, 27 found no relationship with bone health measures, and effects were small in the remaining 9 reports (3 of which were confounded by vitamin D).

Lanou AJ, Berkow SE, Barnard ND Pediatrics, 2005. PMID 15741380

2005 / Narrative review

Optimal vitamin D effects on calcium absorption and fracture reduction occur around 80 nmol/L 25OHD, potentially requiring daily intakes of 2200 IU or more.

This review summarizes advances in vitamin D nutritional physiology since the 1997 DRIs. Available data indicate that intestinal calcium absorption is fully expressed and parathyroid activity minimized at serum 25OHD concentrations around 80 nmol/L, which also reduces osteoporotic fractures. Achieving 80 nmol/L or higher may require daily oral intake of 2200 IU (55 mcg) or more, suggesting the current tolerable upper intake level of 2000 IU/day is too low. Actual toxicity is not observed below serum 25OHD values of 250 nmol/L, requiring intakes over 10,000 IU (250 mcg)/day.

Heaney RP J Steroid Biochem Mol Biol, 2005. PMID 16026981

2005 / Literature review

A review indicates cancer survivors often attempt lifestyle changes, though uptake varies and oncology guidance remains low.

A review of studies from 1966 and beyond assessed prevalent health conditions, persistent lifestyle changes, and intervention outcomes among cancer survivors. Survivors face increased risks of progressive disease, second primaries, osteoporosis, obesity, cardiovascular disease, diabetes, and functional decline. Although survivors frequently initiate diet and exercise changes, only 25% to 42% consume adequate fruits and vegetables, and roughly 70% of breast and prostate cancer survivors are overweight or obese. Male, older, and less educated survivors are less likely to adopt lifestyle changes, and only 20% of oncologists provide health promotion guidance.

Shows an association, not proof of cause and effect.

Demark-Wahnefried W, Aziz NM, Rowland JH, et al. J Clin Oncol, 2005. PMID 16043830

2005 / Narrative review

Fall and injury prevention in elderly people includes interventions such as vitamin D and calcium supplementation, exercise, and hip protectors.

Injuries resulting from falls in elderly people are a major public health concern linked to pain, functional impairment, disability, and death. Existing prevention approaches include regular exercise, vitamin D and calcium supplementation, psychotropic medication withdrawal, cataract surgery, environmental hazard modification, hip protectors, and multifactorial preventive programmes. The authors highlight the need for systematic implementation and careful selection of interventions for those most likely to benefit, noting vitamin D and calcium supplementation and hip protectors for institutionalized elderly individuals.

Kannus P, Sievänen H, Palvanen M, et al. Lancet, 2005. PMID 16310556

2003 / Narrative review with intervention trial data

A low-protein diet reduced intestinal calcium absorption and induced secondary hyperparathyroidism in healthy adults.

The authors reviewed evidence and presented data from short-term nutrition intervention trials in healthy adults consuming low, medium, or high protein diets. The highest protein diet led to hypercalciuria with no change in serum parathyroid hormone. In contrast, the low-protein diet reduced intestinal calcium absorption (measured by dual stable calcium isotopes) and induced secondary hyperparathyroidism within 4 days that persisted for 2 weeks. The long-term consequences on skeletal health remain unknown.

Kerstetter JE, O'Brien KO, Insogna KL J Nutr, 2003. PMID 12612169

2003 / Narrative review

Over-the-counter antacids are the main source of human aluminium exposure, while European patient leaflets vary widely in toxicity warnings.

This review notes that aluminium toxicity, initially linked to bone and brain disorders in chronic renal failure, can occur via dialysis fluids, parenteral nutrition, and oral medications like antacids and phosphate binders. Over-the-counter antacids represent the most important quantitative source of human aluminium exposure, with potential neurotoxic as well as embryonic and fetal toxic effects. However, European patient information leaflets for over-the-counter antacids differ substantially in their warnings, including those regarding increased absorption from concomitant citrate-containing beverages and use during pregnancy.

Reinke CM, Breitkreutz J, Leuenberger H Drug Saf, 2003. PMID 14583063

2002 / Narrative review

Dietary salt intake has several harmful health effects independent of arterial blood pressure.

This review summarizes harmful effects of dietary salt beyond raising blood pressure. High salt intake increases left ventricular mass, thickens and stiffens conduit arteries, thickens and narrows resistance arteries, increases stroke incidence, worsens cardiac failure, and enhances platelet aggregation. It also accelerates renal functional decline in renal disease, affects calcium and bone metabolism linked to bone density in post-menopausal women, influences gastric carcinoma incidence, and may relate to asthma severity in males.

de Wardener HE, MacGregor GA J Hum Hypertens, 2002. PMID 11967714

2002 / Narrative review

The clinical effectiveness of soy protein may depend on an individual's ability to produce the metabolite equol from daidzein.

This review examines the biology, formation, and clinical data regarding equol, a nonsteroidal estrogen produced exclusively by intestinal bacteria from the soy isoflavone daidzein. Equol possesses affinity for estrogen receptors ERalpha and ERbeta and exhibits superior antioxidant activity compared to other isoflavones. Because equol is not produced in all adults, maximal clinical responses to soy diets in cardiovascular, bone, and menopausal health are seen in 'equol-producers.' The authors propose that classifying individuals by their equol-producing status could explain historical variance in soy intervention outcomes.

Setchell KD, Brown NM, Lydeking-Olsen E J Nutr, 2002. PMID 12468591

2001 / Literature review

Prunes contain dietary fiber, sorbitol, phenolics, potassium, and boron, which may support laxative action, cardiovascular health, and bone health.

An extensive literature review summarized the chemical composition and biological effects of prunes on human health. Dried prunes contain approximately 6.1 g of dietary fiber and 14.7 g of sorbitol per 100 g, providing a mild laxative effect and avoiding rapid blood sugar spikes. They also supply 184 mg/100 g of phenolic compounds that inhibit human LDL oxidation in vitro, 745 mg/100 g of potassium, and 2 to 3 mg of boron per 100 g serving. The review notes that more research is needed to determine levels of carotenoids and other phytochemicals to ensure correct labeling and accurate food composition tables.

Stacewicz-Sapuntzakis M, Bowen PE, Hussain EA, et al. Crit Rev Food Sci Nutr, 2001. PMID 11401245